Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 14/20 | 0.49 |
| ▸ | JAK3 | P52333 | 12/20 | 0.49 |
| ▸ | JAK1 | P23458 | 7/20 | 0.49 |
| ▸ | AURKA | O14965 | 1/20 | 0.45 |
| ▸ | ABL1 | P00519 | 1/20 | 0.45 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.45 |
| ▸ | RET | P07949 | 1/20 | 0.45 |
| ▸ | FGR | P09769 | 1/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.45 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.45 |
| ▸ | FLT4 | P35916 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.45 |
| ▸ | FLT3 | P36888 | 1/20 | 0.45 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.45 |
| ▸ | SIK1 | P57059 | 1/20 | 0.45 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.45 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.45 |
| ▸ | GRK6 | P43250 | 1/20 | 0.32 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2243474 | 1.00 | JAK2 (0.49) | JAK2JAK3JAK1AURKAABL1 | |
| SCHEMBL2243337 | 1.00 | JAK2 (0.49) | JAK2JAK3JAK1AURKAABL1 | |
| SCHEMBL2245661 | 0.84 | JAK2 (0.53) | JAK2JAK3JAK1AURKAABL1 | |
| SCHEMBL2246404 | 0.83 | JAK2 (0.49) | JAK2JAK3JAK1AURKAABL1 | |
| SCHEMBL2242556 | 0.83 | JAK2 (0.49) | JAK2JAK3JAK1AURKAABL1 | |
| SCHEMBL2243818 | 0.83 | JAK2 (0.49) | JAK2JAK3JAK1AURKAABL1 | |
| SCHEMBL2243444 | 0.83 | JAK2 (0.50) | JAK2JAK3JAK1AURKAABL1 | |
| SCHEMBL2248660 | 0.83 | JAK2 (0.48) | JAK2JAK3JAK1AURKAABL1 | |
| SCHEMBL2243098 | 0.83 | JAK2 (0.49) | JAK2JAK3JAK1AURKAABL1 | |
| SCHEMBL2248174 | 0.83 | JAK2 (0.50) | JAK2JAK3JAK1AURKAABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110201628-A1 | HETEROCYCLIC JAK KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201628-A1 | HETEROCYCLIC JAK KINASE INHIBITORS | JAK2, JAK1, JAK3 | JAK2 1/4885JAK3 3/4885JAK1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.